PlainRecalls
FDA Devices Moderate Class II Terminated

The ImmunoCard Mycoplasma EIA detects the presence of IgM to M. pneumoniae in serum - Product Usage: intended to aid in the diagnosis of recent Mycoplasma pneumoniae infection.

Reported: March 31, 2021 Initiated: February 8, 2021 #Z-1299-2021

Product Description

The ImmunoCard Mycoplasma EIA detects the presence of IgM to M. pneumoniae in serum - Product Usage: intended to aid in the diagnosis of recent Mycoplasma pneumoniae infection.

Reason for Recall

Use of the kits after incorrect storage could lead to a potential false-negative or invalid result. In the event of a false-negative, the incorrect assumption would be made as to the cause of patient symptoms. The appropriate treatment may not be administered, and symptoms may progress. Additional evaluations will be completed and documented within the associated Health Hazard Evaluation.

Details

Recalling Firm
Meridian Bioscience Inc
Units Affected
8 kits
Distribution
US Nationwide distribution in the states of OH, SC.
Location
Cincinnati, OH

Frequently Asked Questions

What product was recalled?
The ImmunoCard Mycoplasma EIA detects the presence of IgM to M. pneumoniae in serum - Product Usage: intended to aid in the diagnosis of recent Mycoplasma pneumoniae infection.. Recalled by Meridian Bioscience Inc. Units affected: 8 kits.
Why was this product recalled?
Use of the kits after incorrect storage could lead to a potential false-negative or invalid result. In the event of a false-negative, the incorrect assumption would be made as to the cause of patient symptoms. The appropriate treatment may not be administered, and symptoms may progress. Additional evaluations will be completed and documented within the associated Health Hazard Evaluation.
Which agency issued this recall?
This recall was issued by the FDA Devices on March 31, 2021. Severity: Moderate. Recall number: Z-1299-2021.